Company Profile

Mycobacteria Therapeutics Corporation
Profile last edited on: 10/21/21      CAGE: 894A5      UEI: GM5UDR4KWBS4

Business Identifier: soil-derived Immunobiotics for Mental Health
Year Founded
2019
First Award
2020
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

4324 Pecos Street
Denver, CO 80211
   N/A
   N/A
   www.mycotx.com
Location: Single
Congr. District: 02
County: Boulder

Public Profile

Mycobacteria Therapeutics Corp researches and develops beneficial bacterias found in soil and their connection to mental health and the guy-brain relationship. The firm has identified bacteria that regulate the immune system, reduce inflammation, and improve quality of life and can be used to help treat complex diseases.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
0
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 2 NIH $644,076
Project Title: Lead compound discovery from proprietary mycobacterial strains for treatment of PTSD

Key People / Management

  Christopher Stamper -- CEO

  Adam Bohr -- CFO

  Noah Fierer -- CTO

  Christopher A Lowry -- CSO